Literature DB >> 871367

Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.

P W Sheldon, S A Hill.   

Abstract

Tumour experiments including local control after X-irradiation have been performed, using a new technique that eliminates the need for anaesthetics in restraining the animals. This system has been used to investigate the degree of sensitization that can be achieved with ICRF 159 and 4 strongly electron-affinic radiosensitizers, nifurpipone dihydrochloride, metronidazole, Ro-11-3696 and Ro-07-0582. No significant enhancement of the radiation effect was observed with ICRF 159. Significant sensitization was achieved by all 4 nitro-heterocyclic compoinds, Ro-07-0582 being the most effective, metronidazole and Ro-11-3696 the next, and nifurpipone dihydrochloride the least effective. For Ro-07-0582 and metronidazole, several concentrations were investigated, and the interval between injection with Ro-07-0582 and irradiation was varied: an interval of 30 min gave more sensitization than an interval of 90 min. The results from the local control experiments using Ro-07-0582 have been compared with those obtained from regrowth delay experiments. The radiosensitization obtained by the Ro-07-0582 increased with the X-ray dose above 25 gray. Both metronidazole and Ro-07-0582 gave significant enhancement effect at serum concentrations which can be achieved in man.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871367      PMCID: PMC2025527          DOI: 10.1038/bjc.1977.121

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  [Polyneuropathy due to nitrofurantoin therapy].

Authors:  B F DE OLIVARIUS
Journal:  Ugeskr Laeger       Date:  1956-06-28

2.  Metronidazole ("Flagyl"). A radiosensitizer of hypoxic cells.

Authors:  J C Asquith; J L Foster; R L Willson; R Ings; J A McFadzean
Journal:  Br J Radiol       Date:  1974-08       Impact factor: 3.039

3.  Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors.

Authors:  K Hellmann; G E Murkin
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  [Selective alterations of Purkinje cells in the dog after oral administration of high doses of nitroimidazole derivatives (author's transl)].

Authors:  K Schärer
Journal:  Verh Dtsch Ges Pathol       Date:  1972

5.  A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour.

Authors:  L J Peters
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

6.  Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.

Authors:  S A Hill; J F Fowler
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

7.  Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

Authors:  S Dische; M I Saunders; M E Lee; G E Adams; I R Flockhart
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

8.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

9.  Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.

Authors:  P W Sheldon; J L Foster; J F Fowler
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

10.  An experimental method for comparing treatments of intact malignant tumours in animals and its application to the use of oxygen in radiotherapy.

Authors:  R H THOMLINSON
Journal:  Br J Cancer       Date:  1960-09       Impact factor: 7.640

View more
  20 in total

Review 1.  Modifiers of radiosensitivity.

Authors:  A Rojas; J Denekamp
Journal:  Experientia       Date:  1989-01-15

2.  Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.

Authors:  M Tamura; H Inoue; M Murata; H Koizumi; M Nakamura; I Yonome; H Niibe
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

3.  Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.

Authors:  P W Sheldon; J F Fowler
Journal:  Br J Cancer Suppl       Date:  1978-06

4.  Enhancement of local tumour control by misonidazole and hyperthermia.

Authors:  H B Stone
Journal:  Br J Cancer Suppl       Date:  1978-06

5.  Changes in energy metabolism and X-ray sensitivity in murine tumours by the nitric oxide donor SIN-1.

Authors:  P J Wood; J M Sansom; I J Stratford; G E Adams; C Szabo; C Thiemermann; J R Vane
Journal:  Br J Cancer Suppl       Date:  1996-07

6.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.

Authors:  D J Chaplin; M R Horsman; D W Siemann
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

7.  Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.

Authors:  D J Chaplin; M J Trotter; K A Skov; M R Horsman
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

8.  Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.

Authors:  S A Butler; P J Wood; S Cole; C Williams; G E Adams; I J Stratford
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.

Authors:  G E Adams; I Ahmed; P W Sheldon; I J Stratford
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

10.  The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.

Authors:  P W Sheldon; C Clarke; K B Dawson
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.